Respiratory function in patients with chronic heart failure and different ranges of ejection fraction

Spirometrie respiratory impairment is a significant and well-studied predictor for cardiovascular fatality in heart failure. However, reports of the interrelation between spirometric indexes and structural alterations of the heart, particularly left ventricular ejection fraction (LVEF), are scarce. Apparently, the respiratory function differs in patients with different LVEF and influences their clinical phenotype. The aim of this study was to investigate features of external respiration in patients with chronic heart failure (CHF) and different LVEF values. Materials and methods. 78 patients with stable, functional class (FC) I-IV CHF were evaluated and divided into three groups based on their LVEF (impaired, midrange, and preserved). Assessment of the clinical status (Clinical Condition Scale, quality of life, 6-min walk test), EchoCG, and spirometry with the bronchodilation test were performed for all patients. Results. 59.1% of studied patients had normal pulmonary function. 25.6% of patients had restrictive ventilatory defects; 5.1% had obstructive disorders, and 10.2% had mixed disorders. In the patient cohort with restrictive disorders, 55% had FC I-II CHF and 45% had FC III-IV CHF; among patients with obstructive disorders, 25% had FC I-II CHF and 75% had FC III-IV CHF; and among patients with mixed disorders, 12.5% had FC I-II CHF and 87.5% had FC III-IV CHF. Normal ventilatory function was observed in 64.7% of patients with preserved LVEF, 30% of patients with midrange LVEF, and 58.9% of patients with impaired LVEF (<40%). Incidence of restrictive defects was higher in patients with midrange LVEF (40%). Conclusion. Study results indicated presence of both restrictive and obstructive, mixed disorders resulting from secondary changes in lungs due to pulmonary hypertension. Therefore, to improve the treatment tactics spirometry should be performed for all patients with heart failure for timely diagnostics, which would possibly allow to introduce elements of individualized therapy.

фракция выброса, хроническая сердечная недостаточность, спирометрия, ejection fraction, chronic heart failure, spirometry

1. Караськов А. М., Каменская О. В., Клинкова А. С., Чернявский А. М. Хроническая СНисостояние функции внешнего дыхания у пациентов с ИБС. Журнал Сердечная Недостаточность. 2014;15 (2):90-4

2. Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63 (7):599-605.DOI:10.1136/thx. 2007.088112

3. Plesner LL, Dalsgaard M, Schou M, Kober L, Vestbo J, Kjoller E et al. The prognostic significance of lung function in stable heart failure outpatients. Clinical Cardiology. 2017;40 ( 11 ): 1145-51. DOI:10.1002/clc. 22802

4. Мареев В. Ю., Агеев Ф. Т., Арутюнов Г. П., Коротеев А. В., Мареев Ю. В., Овчинников А. Г. и др. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике илечению ХСН (четвертый пересмотр). Утверждены на Конгрессе ОССН 7 декабря 2012 года, на Правлении ОССН 31 марта 2013 и Конгрессе РКО 25 сентября 2013 года. Журнал Сердечная Недостаточность. 2013;14 (7):379-472. DOI:10.18087/rhfj. 2013.7.1860

5. Macchia A., Rodriguez Moncalvo JJ, Kleinert M., Comignani PD, Gimeno G., Arakaki D. et al. Unrecognised ventricular dysfunction in COPD. European Respiratory Journal. 2012;39 (1):51-8. DOI: 10.1183/09031936.00044411

6. Ford I., Robertson M., Komajda M., Böhm M., Borer JS, Tavazzi L. et al. Top ten risk factors for morbidity and mortality in patients with chronic systolic heart failure and elevated heart rate: The SHIFT Risk Model. International Journal of Cardiology. 2015;184:163-9. DOI:10.1016/j. ijcard. 2015.02.001

7. Tsuji K., Sakata Y., Nochioka K., Miura M., Yamauchi T., Onose T. et al. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study: Characterization of HFmrEF. European Journal of Heart Failure. 2017;19 (10):1258-69. DOI:10.1002/ejhf. 807

8. Мухарлямов Н. М. Ранние стадии недостаточности кровообращения и механизмы компенсации. -М.: Медицина; 1978. 248 с.

9. Minasian AG, van den Elshout FJJ, Dekhuijzen PNR, Vos PJE, Willems FF, van den Bergh PJPC et al. Pulmonary function impairment in patients with chronic heart failure: Lower limit of normal versus conventional cutoff values. Heart & Lung: The Journal of Acute and Critical Care. 2014;43 (4):311-6. DOI:10.1016/j. hrtlng. 2014.03.011

10. Dalsgaard M., Plesner LL, Schou M., Kjoller E., VestboJ, Iversen K. Prevalence of airflow obstruction in patients with stable systolic heart failure. BMC Pulmonary Medicine [Интернет]. 2017 [цитируется по 14 июль 2018 г.];17 (1). DOI:10.1186/s12890-016-0351-9

11. Ponikowski P., Voors AA, Anker SD, Bueno H., Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37 (27):2129-200. DOI:10.1093 / eur-heartj/ ehw128

12. Lam CSP, Solomon S.D. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%). European Journal of Heart Failure. 2014;16 (10):1049-55. DOI:10.1002/ejhf. 159